Clinical Trials Browser

Observational × Graft vs Host Disease × 1 year × Clear all

Graft vs Host Disease, Neoplasms, Plasma Cell

NCT07235501 2026-03-13

Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell Transplantation

Not yet recruiting

75 enrolled

Graft vs Host Disease

NCT02422875 2025-09-30

Comparative Autoantibody and Immunologic Cell Marker Study

Enrolling by invitation

2,500 enrolled

Undifferentiated Connective Tissue Diseases, Immunoglobulin G4-Related Disease, Acquired Immunodeficiency Syndrome, Arthritis, Arthritis, Juvenile, Arthritis, Rheumatoid, Autoimmune Diseases, Communicable Diseases, Graft vs Host Disease, Hepatitis C, Lupus Erythematosus, Systemic, Myositis, Sjogren's Syndrome, Purpura, Thrombocytopenic, Idiopathic, Sepsis, Epstein-Barr Virus Infections, Guillain-Barre Syndrome, Scleroderma, Diffuse, Autoimmune Lymphoproliferative Syndrome

NCT05362630 2025-06-05

Infliximab Efficacy, TDM and Serum TNFα Levels in Pediatric HSCT Recipients With aGVHD: Prospective Observational Study

Completed

28 enrolled

Graft vs Host Disease

NCT06321003 2025-05-23

SYMILIS OCT

Recruiting

200 enrolled

DermatologicHead & Neck

Actinic cheilitis, Squamous Cell Carcinoma of Head and Neck, Graft vs Host Disease, Leukoplakia, Oral, Mouth Diseases, Mouth Neoplasms, Lichen Planus, Oral, Keratosis, Actinic

NCT05124288 2025-05-13

GITMO-RELAPSE

Recruiting

500 enrolled

Other hematologic neoplasm

Graft vs Host Disease, Leukemia, Myeloid, Acute

Clinical Trials

Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants

Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell Transplantation

Comparative Autoantibody and Immunologic Cell Marker Study

Infliximab Efficacy, TDM and Serum TNFα Levels in Pediatric HSCT Recipients With aGVHD: Prospective Observational Study

SYMILIS OCT

GITMO-RELAPSE